U.S. advisory panel makes no decision on pause to J&J's COVID-19 vaccine

Health News
FILE PHOTO: Vials labelled “COVID-19 Coronavirus Vaccine” and sryinge are seen in front of displayed Johnson&Johnson logo in this illustration taken, February 9, 2021. REUTERS/Dado Ruvic/Illustration

(Reuters) – A U.S. health advisory panel on Wednesday did not make a decision related to the pause in the use of Johnson & Johnson’s COVID-19 vaccine, and aimed to reconvene possibly in a week or 10 days.

Source: Read Full Article

Related posts:
  1. Novavax expects to produce 150 million vaccine doses per month as early as May: CEO
  2. Italy aims to vaccinate at least 80% of population by end of September
  3. U.S. puts J&J in charge of plant that botched COVID vaccine, removes AstraZeneca